Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
3d
Van Lanschot Kempen Life Sciences Conference MADRID, Spain and CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to ...
GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB , a company discovering and developing novel ...
The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
Beckley Psytech has completed subject enrolment for the core stage of the global Phase IIb clinical trial of patent-protected ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Q4 2024 Earnings Call Transcript February 28, 2025 Longeveron Inc. beats earnings expectations. Reported EPS is $1.16, ...
Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effectsRamat Gan, Israel, March 03, ...
Additional finalized Phase IIa clinical trials with vafidemstat include the ETHERAL ... randomized, double blind Phase IIb PORTICO trial (final data presented at ECNP-2024). Following receipt of the ...
CAIRO, March 2 (Reuters) - Hamas will not agree to extend the first phase of the Gaza ceasefire deal as requested by Israel, a senior Hamas official said Sunday. Speaking to Al Jazeera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback